Expected U.S. approval of long-acting Cytopoint in 2026
Full international launches and subsequent expansion of Lenivia and Portela osteoarthritis products
Commercial validation of Vetscan OmniMax diagnostics platform expected by end-2026
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Zoetis Inc. and 4,900+ companies.